In lung SCC with lymph node metastasis, Cav-1 is mainly detected in stage III, and Cav-1-positive patients show a lower 5-year survival rate compared to the Cav-1-negative patients [33]. This evidence concerns the gene CAV1 and metastatic malignant neoplasm in the lymph nodes.